Goal of the analysis:
Ensure that all labeling meets applicable regulatory requirements, and confirm that Unique Device Identification (UDI) systems are properly implemented for each device. This includes verifying that device labels are accurate, compliant, and traceable across different markets.
Data required:
- Current labeling artwork, product packaging, and instructions for use (IFU)
- Applicable regulatory guidelines (for example, FDA’s UDI Rule, EU MDR requirements)
- List of device product codes and device identifiers (DI)
- Label control procedures and records of label revisions
- UDI assignment records and database submission details (for example, GUDID in the US)
- Any known complaints or post-market feedback related to labeling issues
Detailed step-by-step instruction on how to conduct the analysis:
- Identify relevant UDI and labeling regulations. Determine the specific requirements for each target market, including UDI standards, language requirements, and required symbols/warnings.
- Gather all current device labels and IFUs. Collect product labels, packaging inserts, and electronic labeling (if applicable) to ensure comprehensive assessment.
- Check label content against regulations. Verify that mandatory information (such as device name, intended use, manufacturer details, symbols, and warnings) is clearly presented and compliant.
- Assess the UDI markings. Confirm that UDI codes are correctly assigned, formatted, and placed on labels or direct parts where required, following standards like GS1 or HIBCC.
- Review UDI database submissions. Evaluate whether required information has been accurately submitted to regulatory databases (for example, FDA GUDID, EUDAMED) and is kept current.
- Check version control and labeling SOPs. Confirm that labeling processes include procedures for updating and controlling changes, with documented revision histories.
- Interview or survey stakeholders. Speak with packaging and regulatory teams to gauge their understanding of UDI and labeling requirements.
- Identify any labeling gaps or inconsistencies. Note issues such as missing elements, unclear language, or noncompliant symbols.
- Prepare a compliance action plan. Summarize findings, recommend corrective actions, and establish timelines and responsibilities.
Format of the output of analysis:
- A written assessment report with a list of identified noncompliance or improvement areas
- A gap analysis chart mapping current labeling content vs. regulatory requirements
- UDI compliance checklist indicating status of labeling and database submissions
- An action plan outlining corrective steps, responsible owners, and completion dates
How to interpret results:
- Labels that fully meet regulatory criteria, including correct UDI markings, indicate strong compliance.
- Missing or incorrect labeling elements, inadequate language translations, or incomplete UDI records signal compliance risk.
- Repeated labeling or UDI errors could reflect broader document control or quality system weaknesses.
Steps a company can take to improve on this measure:
- Establish a clear labeling SOP that addresses all regulatory requirements and includes a robust change control process.
- Provide regular training to ensure teams understand evolving UDI and labeling regulations across global markets.
- Implement software solutions for label design, version control, and UDI database submissions to reduce manual errors.
- Conduct periodic internal audits to verify the accuracy and compliance of labeling and UDI submissions.
- Collaborate with cross-functional teams (for example, regulatory, manufacturing, logistics) to maintain synchronized updates.
Request the PDF Download of How to Analyze a Medical Devices Company
Menu of the analyses:
Table of Contents
A. Regulatory & Compliance
- Regulatory Pathway Analysis
- Regulatory Compliance and Quality Management Systems Review
- Labeling and Unique Device Identification (UDI) Compliance Assessment
- Device Classification and Product Code Analysis
- Combination Product Regulatory Strategy
- EU MDR/IVDR Compliance Gap Analysis
- MDSAP (Medical Device Single Audit Program) Readiness and Gap Analysis
- OTC vs. Prescription Device Classification Feasibility
- Reprocessing and Re-Manufacturing Compliance Assessment
- Software Update Lifecycle (IEC 62304) Compliance Review
B. Clinical & Post-Market
- Clinical Evidence Review
- Post-Market Surveillance and Vigilance
- CRO and Clinical Site Management Efficiency Analysis
- Real-World Evidence Generation Strategy for Device Performance
- Clinical Evidence Gap Analysis
- Comparative Efficacy and Safety Benchmarking vs. Standard of Care
- Field Safety Corrective Action and Recall Readiness Evaluation
- Patient Engagement and Compliance Tracking for Home-Use Devices
C. Reimbursement & Market Access
D. Product Development & Lifecycle
E. Operations & Supply Chain
F. Risk Management & Quality
G. Commercial Strategy & Marketing
H. Technology & Innovation
- Software as a Medical Device (SaMD) and Cybersecurity Risk Assessment
- Device Tracking and Traceability Program Analysis
- Human Factors Engineering and Usability Evaluation
- Material Compatibility and Biomaterial Selection Analysis
- Clinical Data Integration with Wearables and IoT Devices
- Calibration and Maintenance Program for Reusable Devices
- In-Vitro Diagnostic (IVD) Connectivity with Laboratory Information Systems (LIS) Workflow Analysis
- Remote Servicing and Maintenance Approach for Connected Medical Devices
I. Intellectual Property
J. Sustainability & Environmental Impact